Related Experiment Videos
Outcome prediction in critical care: the Acute Physiology and Chronic Health Evaluation models
Jack E Zimmerman1, Andrew A Kramer
1Anesthesia and Critical Care Medicine, The George Washington University, Washington, District of Columbia, USA.
Purpose Of Review:
A new generation of predictive models for critically ill patients was described between 2005 and 2008. This review will give details of the latest version of the Acute Physiology and Chronic Health Evaluation (APACHE) predictive models, and discuss it in relation to recent critical care outcome studies. We also compare APACHE IV with other systems and address the issue of model complexity.
Recent Findings:
APACHE IV required the remodeling of over 40 equations. These new models calibrate better to contemporary data than older versions of APACHE and there is good predictive accuracy within diagnostic subgroups. Physiology accounts for 66% and diagnosis for 17% of the APACHE IV mortality model's predictive power. Thus, physiology and diagnosis account for 83% of the accuracy of APACHE IV.
Summary:
Predictive models have a modest window of applicability, and therefore must be revalidated frequently. This was shown to be true for APACHE III, and hence a major reestimation of models was carried out to generate APACHE IV. Although overall model accuracy is important, it is also imperative that predictive models work well within diagnostic subgroups.
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacodynamic Models: Overview
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Acute Respiratory Failure-III